Light Mode
$47.93 ↑ +0.00 (+0.00%) Trading Up from the previous close of $47.93, $0.14 below the day’s high of $48.07
+13.60 (+39.62%) / 6M
Momentum, market sentiment, and recent alerts
VCYT reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +30.5%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.